Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR26F55XT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,380
Award facts
- Contract value 100% obligated
- $29,379.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) valued at $29,379.57 with a firm fixed price structure. The award, issued on November 5, 2025, represents a non-competitive delivery against an existing contract vehicle and does not include any small business set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is structured as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026.
The Vraylar delivery order supports the Defense Logistics Agency's medical supply operations serving military healthcare systems and the Defense Health Agency. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor supplying brand-name and generic medications, including neurological and psychiatric treatments, across multiple therapeutic domains. The IDC vehicle under which this delivery order was issued enables flexible procurement of pharmaceuticals and medical supplies to support defense health requirements globally, with the company competing alongside other prime vendors in the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DR26F55XT?
SPE2DR26F55XT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F55XT worth?
The government has obligated $29,380 on SPE2DR26F55XT.
Is contract SPE2DR26F55XT an order under another contract?
Yes. SPE2DR26F55XT is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F55XT competed?
The extent of competition for SPE2DR26F55XT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award